Table 3.
Clinical and laboratory characteristics of subjects for each group of criteria
| Characteristic | NCEP ATP III | Weiss et al12 | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| MS (n = 63) | No MS (n = 37) | P-value | MS (n = 39) | No MS (n = 61) | P-value | |
| Sex (M/F) | 24/39 | 18/19 | NS | 19/20 | 24/37 | NS |
| Age (year)* | 10.72 ± 2.49 | 10.19 ± 2.50 | NS | 11.06 ± 2.19 | 10.07 ± 2.58 | NS |
| BMI (kg/m2)* | 26.43 ± 3.81 | 25.27 ± 5.24 | NS | 27.45 ± 3.77 | 25.06 ± 4.51 | 0.008 |
| WC (cm)* | 87.31 ± 10.17 | 83.07 ± 16.37 | NS | 89.80 ± 9.92 | 83.15 ± 13.82 | 0.011 |
| Hip circumference (cm)* | 0.90 ± 0.05 | 93.42 ± 13.51 | NS | 99.07 ± 8.96 | 92.64 ± 12.59 | 0.007 |
| WHR* | 0.902 ± 0.069 | 0.89 ± 0.08 | NS | 0.90 ± 0.05 | 0.893 ± 0.075 | NS |
| TGs (mg/dL)** | 175 (91–750) | 92 (41–177) | <0.001 | 184 (110–750) | 118.5 (41–259) | <0.001 |
| Total cholesterol (mg/dL)* | 180.06 ± 48.47 | 154.79 ± 35.22 | 0.009 | 183.79 ± 52.92 | 162.74 ± 38.38 | 0.025 |
| HDL-C (mg/dL)* | 40.67 ± 9.16 | 48.91 ± 12.32 | 0.001 | 39.59 ± 11.02 | 46.22 ± 10.31 | 0.003 |
| LDL-C (mg/dL)* | 105.77 ± 37.28 | 92.22 ± 27.01 | NS | 107.82 ± 40.78 | 96.45 ± 29.4 | NS |
| SBP (mmHg) | 31 (49.2) | 3 (8.1) | 0.000 | 25 (64.1) | 8 (13.8) | 0.000 |
| DBP (mmHg) | 23 (36.5) | 1 (2.27) | 0.000 | 19 (48.7) | 4 (6.9) | 0.000 |
| Hypertension (n) | 33 (52.4) | 3 (8.1) | 0.000 | 27 (69.2) | 8 (12) | 0.000 |
| Fasting blood glucose (mg/dL)* | 91.98 ± 7.66 | 88.35 ± 8.20 | 0.032 | 93.89 ± 7.52 | 88.56 ± 7.66 | 0.001 |
| Blood glucose after 2 hours (mg/dL)* | 104.65 ± 17.11 | 97.54 ± 28.29 | NS | 105.38 ± 18.76 | 99.68 ± 24.30 | NS |
| Fasting insulin (μIU/mL)** | 19.1 (6.1–76.8) | 11.8 (5.7–60) | 0.048 | 21.5 (6.1–76.8) | 12.6 (5.7–60) | 0.001 |
| Insulin after 2 hours (μIU/mL)** | 67.15 (9.2–351) | 44 (6.2–138.7) | 0.001 | 62 (9.2–351) | 56.9 (6.2–211.3) | NS |
| HOMA-IR** | 4.28 (1–20.48) | 2.96 (1.05–19.77) | NS | 4.88 (1–20.48) | 3.11(1.05–19.77) | 0.004 |
| IR (n) | 52 | 29 | NS | 34 | 47 | NS |
| Uric acid (mg/dL)* | 5.33 ± 1.18 | 4.93 ± 1.12 | NS | 5.44 ± 1.10 | 5.01 ± 1.19 | NS |
*
Notes: Data presented as mean plus or minus standard deviation;
**
data presented as median (minimum to maximum).
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model of insulin resistance; IR, insulin resistance; LDL-C, low-density lipoprotein cholesterol; MS, metabolic syndrome; NCEP ATP III, National Cholesterol Education Program’s Adult Treatment Panel III criteria; NS, not significant; SBP, systolic blood pressure; TGs, triglycerides; WC, waist circumference; WHR, waist-to-hip ratio.